2M6 Stock Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Medtronic plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$73.91 |
52 Week High | US$83.44 |
52 Week Low | US$65.00 |
Beta | 0.78 |
1 Month Change | -4.06% |
3 Month Change | -6.42% |
1 Year Change | -3.13% |
3 Year Change | -31.91% |
5 Year Change | -5.24% |
Change since IPO | 1.03% |
Recent News & Updates
Recent updates
Shareholder Returns
2M6 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -3.5% | -5.1% | -1.5% |
1Y | -3.1% | -9.0% | 0.9% |
Return vs Industry: 2M6 exceeded the German Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: 2M6 underperformed the German Market which returned -0.4% over the past year.
Price Volatility
2M6 volatility | |
---|---|
2M6 Average Weekly Movement | 2.2% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2M6 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2M6's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
Medtronic plc Fundamentals Summary
2M6 fundamental statistics | |
---|---|
Market cap | €98.65b |
Earnings (TTM) | €3.95b |
Revenue (TTM) | €30.36b |
25.0x
P/E Ratio3.3x
P/S RatioIs 2M6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2M6 income statement (TTM) | |
---|---|
Revenue | US$32.32b |
Cost of Revenue | US$11.08b |
Gross Profit | US$21.24b |
Other Expenses | US$17.04b |
Earnings | US$4.20b |
Last Reported Earnings
Jan 26, 2024
Next Earnings Date
May 23, 2024
Earnings per share (EPS) | 3.16 |
Gross Margin | 65.72% |
Net Profit Margin | 13.00% |
Debt/Equity Ratio | 48.3% |
How did 2M6 perform over the long term?
See historical performance and comparison